The genotoxicity of cisplatin towards nuclear DNA is not sufficient to explain the cisplatin resistance of hepatocellular carcinoma (HCC) cells; cisplatin interacts with many organelles, which can influence the sensitivity. Here, we explored the role of mitochondrial-lysosomal crosstalk in the cisplatin resistance of HCC cells.
| INTRODUC TI ON
Cisplatin (cis-diamminedichloroplatinum(II), CDDP), as a representative platinum drug, has shown efficacy in hepatocellular carcinoma (HCC) treatment, [1] [2] [3] [4] but most hepatobiliary cancer guidelines do not recommend cisplatin as a first-line treatment because of the low sensitivity of this drug to HCC. [5] [6] [7] [8] [9] Cisplatin has also been shown to induce DNA damage; however, recent studies have found that genotoxicity accounts for only a small portion of the cytotoxicity of this drug. 10 Cisplatin can also interact with mitochondria, lysosomes, the endoplasmic reticulum and other organelles, 11, 12 influencing the sensitivity of tumour cells to cisplatin. Therefore, identification of the target of cisplatin in HCC cells is very important for elucidation of the resistance mechanism. protein samples were separated by 12% SDS-PAGE and then transferred to PVDF membranes (Roche, Switzerland). The membranes were blocked with 5% (w/v) skim milk for 2 hours and then incubated with the different desired antibodies at 4°C overnight. Then, the membranes were incubated with the corresponding secondary antibodies at room temperature for 1.5 hours. Immunodetection was performed using ECL reagent (Thermo Fisher Scientific, Inc, USA), and visualization was performed using a Syngene bioimaging system (Synoptics, UK). Protein levels were quantified using Quantity One software and normalized to β-actin.
| Immunofluorescence staining and confocal laser microscopy
Cells were seeded onto coverslips in 24-well plates overnight and exposed to different experimental conditions, and then, the cells were fixed in 4% (w/v) paraformaldehyde/PBS for 20 minutes. After fixation, the cells were subjected to proteinase K digestion for 1 minute, permeabilized with 0.1% Triton X-100 for 5 minutes and blocked with bovine serum albumin for 30 minutes. The cells were incubated with primary antibody overnight at 4°C and then stained with FITCconjugated secondary antibodies (1:500 dilution) for 30 minutes in the dark. The cells were then treated with Hoechst 33342/H 2 O (1 μg/mL) for 2 minutes. For staining of mitochondria and lysosomes, the cells were incubated with MitoTracker RED (200 nmol/L, 30 minutes), LysoTracker Green (50 nmol/L, 60 minutes) or DQ Red BSA (10 µg/mL, 2 hours). After rinsing with PBS, images were acquired by using an Olympus FV1000 confocal laser microscope (Olympus Corporation, Japan).
| Oxygen consumption rate
Cells were plated in 96-well plates at a density of 8 × 10 4 cells/ well overnight. Then, the medium in all the wells was replaced with a preheated liquid mixture containing reconstituted MitoXpress-Xtra reagent, fresh culture medium and the different treatments. The wells were then sealed using preheated mineral oil.
Fluorescence decay was measured using a CLARIOstar microplate reader.
| Reverse transcription-quantitative polymerase chain reaction analysis
TRIzol (Invitrogen) was used to extract the total cellular RNA, and reverse transcription was performed to generate cDNA, which was amplified using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The primer sequences are listed in 
| RT 2 profiler PCR array system
The RT 2 Profiler PCR array system for human mitochondrial energy metabolism (PAHS-008Z; Qiagen, Germany) profiles the expression of 84 key genes involved in human mitochondrial energy metabolism (Supporting Information Table S1 ). RT-qPCRs were performed using a CFX96 Touch Real-Time PCR detection system.
Fluorescence intensities were analysed using Qiagen online software, and relative quantification was performed using the 2 −ΔΔC t method. Changes in expression of the 84 genes were visualized as a heatmap.
| Statistical analysis
All the data are representative of three independent experiments, each performed in triplicate. Statistical significance was analysed using one-way ANOVA, followed by Tukey or Newman-Keuls post hoc analysis. The analyses were performed with GraphPad Prism 5.0 statistical software (USA). *P < 0.05 was considered to indicate statistical significance; **P < 0.01 indicated a highly significant difference; and ***P < 0.001 indicated an extremely significant difference.
| RE SULTS

| Mitochondria are important targets of cisplatin in HCC cells
The MTT assay was used to evaluate cell metabolic activity ( Figure 1A,B ). MitoSOX Red is a fluorogenic dye for mtROS 40 that can be used to determine mtROS levels. The mtROS levels increased in HCC cells treated with cisplatin in a time-dependent manner ( Figure 1C ,D). Because mtROS accumulation is an important indicator of mitochondrial dysfunction, 41 mitochondrial energy metabolism was next evaluated by the appropriate PCR array and based on the extracellular oxygen consumption rate (OCR). The PCR array showed that most of the mitochondrial respiratory complex-related genes were downregulated in Huh7 cells treated with cisplatin ( Figure 1E ), and cisplatin decreased the OCR in HCC cells ( Figure 1F ). MitoTracker Green FM staining showed that the fluorescence intensity increased in a time-dependent manner in HCC cells ( Figure 1G ,H). These results showed that mitochondria are important targets of cisplatin in HCC cells and that cisplatin can damage mitochondria and increase mtROS levels, leading to accumulation of damaged mitochondria.
| Cisplatin induced mitochondrial fission and the mitophagy-lysosomal pathway in HCC cells
Reactive oxygen species damage mitochondria, which initiates mitochondrial quality control for maintenance of mitochondrial homeostasis. 42 To determine whether HCC cells overcome cisplatin-induced mitochondrial damage in this manner, the cells were cultured with cisplatin for various durations, stained with MitoTracker Red CMXRos and observed by confocal microscopy (Figure 2A ). In the absence of treatment, the mitochondria in HepG2 and Huh7 cells were long and tubular. After exposure to cisplatin for 12 hours, the mitochondrial morphology was fragmented, exhibiting short tubular shapes. After exposure for 24 hours, the mitochondria appeared as small dots, indicating that cisplatin induced mitochondrial fission in HCC cells.
Selected Huh7 cells with a high degree of mitochondrial fission were examined by Western blotting. After cisplatin treatment, the expression of the mitochondrial fusion proteins Mfn1 and Mfn2 decreased significantly, while that of the mitochondrial fission proteins FIS1 and Drp1 increased significantly ( Figure 2B ). Mitochondrial fission can isolate damaged mitochondria and degrade these mitochondria via mitophagy. 23 To further determine whether cisplatin induced mitophagy in HCC cells, we detected the expression of the mitophagy- 
| Cisplatin induced lysosomal biogenesis in HCC cells, contributed to mitophagy and caused synergistic mitochondrial-lysosomal crosstalk
Mitophagy consumes large numbers of lysosomes. 43 To verify the enhancement of lysosome biogenesis in HCC cells induced by cisplatin, LysoTracker Green staining was used to quantify lysosome levels. Lysosome numbers were shown to increase in a time-dependent manner ( Figure 3A,B ). DQ Red BSA, which is a red BODIPY dye conjugated to bovine serum albumin and the proteolysis of which leads to dequenching and the release of red fluorescence, 44 was next used to evaluate lysosomal phagocytosis and degradation. The fluorescence intensity of HCC cells treated with cisplatin was observed to increase gradually in a time-dependent manner ( Figure 3C ,D). To elucidate the underlying mechanism, we detected the activation of TFEB, a key molecule associated with lysosomal biogenesis. We showed that cisplatin increased the expression of TFEB and activated the translocation of TFEB to the nucleus ( Figure 3E ). Elements of the coordinated lysosomal expression and regulation (CLEAR) system were previously shown to bind TFEB and initiate lysosomal biogenesis. 45 Therefore, we examined the expression of key genes in the CLEAR network by RT-qPCR. We found that cisplatin signifi- Table S1 . Changes are presented as a heatmap; green indicates downregulation, and red indicates upregulation. Data were derived from three experiments. F, OCR was measured after Huh7 cells were treated with 8 μg/mL cisplatin and HepG2 cells were treated with 12 μg/mL cisplatin. Relative OCR values are expressed as the mean ± SD; n = 3, ***P < 0.001. G, Huh7 cells were treated with 8 μg/mL cisplatin and H, HepG2 cells were treated with 12 μg/mL cisplatin for varying durations. Then, the cells were stained with MitoTracker Green FM and detected using flow cytometry. The percentage of cells with high MitoTracker fluorescence is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, ***P < 0.001 was aggravated, in the group treated with CQ and cisplatin. We also evaluated the mitochondrial membrane potential using JC-1 and obtained similar results ( Figure 4G ). Annexin V-FITC(+) staining showed that, compared with cisplatin alone, treatment with rapamycin reduced the apoptosis rate in HepG2 and Huh7 cells, while treatment with CQ enhanced cisplatin-induced apoptosis in HCC cells F I G U R E 2 Cisplatin induced mitochondrial fission and the mitophagy-lysosomal pathway in HCC cells. A, Huh7 cells were treated with 8 μg/mL cisplatin, and HepG2 cells were treated with 12 μg/mL cisplatin for 12 and 24 h. Then, the cells were stained with MitoTracker Red CMXRos and observed by confocal laser microscopy; scale bar = 10 μm. B, Western blot detection of mitochondrial fusion proteins and mitochondrial fission proteins in Huh7 cells treated with 8 μg/mL cisplatin for 6, 12 and 24 h. The protein/beta-actin ratio is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01. C, Western blot detection of mitophagy-lysosomal pathway-related proteins in Huh7 cells treated with 8 μg/mL cisplatin for 6, 12 and 24 h. The protein/beta-actin ratio is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, ***P < 0.001 F I G U R E 3 Cisplatin induced lysosomal biogenesis in HCC cells. A, Huh7 cells were treated with 8 μg/mL cisplatin, and B, HepG2 cells were treated with 12 μg/mL cisplatin for varying durations. Then, the cells were stained with LysoTracker Green DND-26 and detected using flow cytometry. The percentage of cells with high LysoTracker fluorescence is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01. C, Huh7 cells were treated with 8 μg/mL cisplatin, and D, HepG2 cells were treated with 12 μg/mL cisplatin for varying durations. Then, the cells were stained with DQ Red BSA and detected using flow cytometry. The percentage of cells with high DQ Red BSA fluorescence is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01. E, Colocalization of TFEB and nuclei in Huh7 cells treated with 8 μg/mL cisplatin and HepG2 cells treated with 12 μg/mL cisplatin for 8 h; scale bar = 10 μm. The percentage of nuclear localization is analysed by ImageJ and expressed as the mean ± SD; n = 3, ***P < 0.001. F, The mRNA levels of TFEB and the CLEAR system in Huh7 cells treated with 8 μg/ mL cisplatin and G, HepG2 cells treated with 12 μg/mL cisplatin for 8 h. Relative mRNA expression is expressed as the mean ± SD; n = 3, **P < 0.01, ***P < 0.001
| Mitochondrial-lysosomal crosstalk was important for the resistance of HCC cells to cisplatin
( Figure 4H,I) . Taken together, these results indicated that mitochondrial-lysosomal crosstalk plays a protective role in the resistance of HCC cells to cisplatin. leading to a decrease in red fluorescence. 39, 49 The red fluorescence intensity of the groups treated with PKI-402 alone or cisplatin alone decreased slightly, while that of the group treated with PKI-402 and cisplatin decreased significantly, in Huh7 cells ( Figure 6B ). Then, we extracted the cytoplasmic proteins and measured the protein levels of cathepsin B, cathepsin D and cytochrome C by Western blotting ( Figure 6D ). The protein levels in the cytoplasm of cells treated with cisplatin alone or PKI-402 alone were slightly higher than those of the control group, but the levels were significantly higher than those of the group treated with PKI-402 and cisplatin. Additionally, JC-1 staining revealed a significant decrease in the mitochondrial membrane potential of cells treated with PKI-402 and cisplatin, while E-64 increased the mitochondrial membrane potential to some extent ( Figure 6C ). The above results showed that the mtROS levels in HCC cells increased after PI3K/mTOR inhibition and that combinatorial treatment with cisplatin could further increase the mtROS levels in HCC cells, leading to LMP, mitochondrial depolarization, mitochondrial outer membrane permeabilization (MOMP) and apoptosis.
| Cisplatin combined with the PI3K/mTOR inhibitor PKI-402 destroyed mitochondrial-lysosomal crosstalk and induced LMP in HCC cells
| D ISCUSS I ON
Mitochondria are responsible for regulating various forms of cell death, including apoptosis and necrosis. 50 Therefore, to resist chemotherapeutic drugs, cancer cells must maintain mitochondrial homeostasis. Although most previous studies have suggested that the main target of cisplatin is nuclear DNA, recent studies have found that mitochondria are critical targets of cisplatin, 11 and this finding was supported by our present findings in HCC cells. The underlying mechanism may be associated with the genotoxicity of cisplatin towards mtDNA 51 ; cisplatin binds to mtDNA with higher efficiency than to nuclear DNA, 52 but the efficiency of DNA repair in mitochondria is consistently low. However, cells initiate mitophagy to maintain organelle homeostasis. Mitochondrial fission is considered to be a sorting mechanism for mitophagy, as demonstrated by PINK1/parkin-mediated mitophagy. Loss of the mitochondrial membrane potential will stabilize PINK1 at the outer membrane, which can recruit parkin, leading to mitochondrial fragmentation and subsequent mitophagy. 23, 43, 53 However, it is unknown whether there exists a similar mechanism of cisplatin resistance in HCC cells. In the F I G U R E 4 Mitochondrial-lysosomal crosstalk was important for the resistance of HCC cells to cisplatin. A, Western blot detection of mitophagy-lysosomal pathway-related proteins in Huh7 cells treated with 8 μg/mL cisplatin and/or 20 μmol/L CQ for 24 h. The protein/ beta-actin ratio is expressed as the mean ± SD; n = 3, **P < 0.01, ***P < 0.001. B, Huh7 cells were treated with 8 μg/mL cisplatin combined with 20 μmol/L CQ or 5 μmol/L rapamycin for 24 h and then stained with MitoSOX Red and detected using flow cytometry. The percentage of cells with high MitoSOX fluorescence is expressed as the mean ± SD; n = 3, **P < 0.01, ***P < 0.001. C, Huh7 cells (same treatment as A) and D, HepG2 cells were treated with 12 μg/mL cisplatin combined with 20 μmol/L CQ or 5 μmol/L rapamycin for 24 h and then stained with MitoTracker Green FM and detected using flow cytometry. The percentage of cells with high MitoTracker fluorescence is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, ***P < 0.001. E, OCR was measured after Huh7 cells were treated with 8 μg/mL cisplatin combined with 20 μmol/L CQ or 5 μmol/L rapamycin. Relative OCR values are expressed as the mean ± SD; n = 3, *P < 0.05. F, OCR was measured after HepG2 cells were treated with 12 μg/mL cisplatin combined with 20 μmol/L CQ or 5 μmol/L rapamycin. Relative OCR values are expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01. G, Huh7 cells were stained with JC-1 and analysed by FlowJo. The percentage of cells with low red fluorescence and high green fluorescence is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01. H, Huh7 cells and I, HepG2 cells were stained with Annexin V and PI and analysed by FlowJo. The percentage of cells with high Annexin V-FITC fluorescence is expressed as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, ***P < 0.001 present study, we showed that cisplatin can induce mitochondrial fission and depolarization in HCC cells, which is a precondition of mitophagy. 43 Western blot analysis showed that cisplatin activated PINK1/parkin-mediated mitophagy in HCC cells, which selectively targeted impaired mitochondria for degradation. The autophagy inhibitor CQ can inhibit mitophagy effectively and increase the cell which is a transcription factor that is responsible for regulation of mitochondrial biogenesis. 57 Whether PGC-1α is activated by TFEB to supplement degraded mitochondria by mitophagy and maintain mitochondrial homeostasis needs further verification.
Lysosomal membrane stability is a prerequisite for lysosomal function and mitophagy. PI3K signalling regulates lysosomal maturation, size and activity and is involved in the control of lysosomal stability, 38, 39, 58 and PI3K/mTOR inhibitors were reported to cause LMP. 39, [59] [60] [61] In this study, we showed that cisplatin combined with the dual PI3K/mTOR inhibitor PKI-402 induced LMP in HCC cells.
Recent studies have suggested that mtROS production is a major inducer of LMP. 30 We also found that PKI-402 elevated mtROS levels in HCC cells, which were further enhanced by cisplatin. Interestingly, we found that cisplatin caused a low degree of LMP in HCC cells.
This finding is consistent with other studies that reported that an interaction between cisplatin and lysosomes caused LMP accompanied by apoptosis, which may be associated with the accumulation of cisplatin in lysosomes, where this compound initiates LMP.
We showed that LMP induced by PKI-402 combined with cispla- We also found that mtROS levels were positively correlated with LMP, mitochondrial depolarization and apoptosis, suggesting that mtROS levels are associated with mitochondrial and lysosomal damage, which further aggravate the accumulation of mtROS. Therefore, F I G U R E 7 Cisplatin combined with PKI-402 changed the role of the lysosome from a protective one to that of a cell death promoter in HCC cells mtROS is an important positive feedback regulator that destroys mitochondrial-lysosomal crosstalk.
In summary, we provide evidence that mitochondria are important targets of cisplatin in HCC cells. Cisplatin-induced mitophagy and lysosomal biogenesis constitute mitochondrial-lysosomal crosstalk, which is a crucial mechanism by which HCC cells overcome the cytotoxicity of cisplatin. We also showed that a combination of cisplatin and the PI3K/mTOR inhibitor PKI-402 induced LMP in HCC cells and then destroyed cisplatin-induced mitochondrial-lysosomal crosstalk, which significantly increased the sensitivity of HCC cells to cisplatin (Figure 7) . This study will provide new ideas and candidate targets for comprehensive treatment of HCC. 
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